| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.003 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.19 | 0.004 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.18 | 0.4 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.17 | 0.01 |